Fosun Pharmaceutical (600196.SH) released its first quarter results, with a net profit attributable to shareholders of 765 million yuan, an increase of 25.42% year-on-year.

Sina Finance News, Fosun Pharma (600196.SH) released its first quarter report for 2025, with a first quarter operating income of 9.42 billion yuan; net profit attributable to the company's shareholder was 765 million yuan, a year-on-year increase of 25.42%; net profit attributable to the company's shareholder after deducting non-recurring gains and losses was 4.10 billion yuan; basic earnings per share was 0.29 yuan per share.